Short ReportRisk of hepatocellular carcinoma in relation to ABO blood type
Introduction
Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer worldwide, its incidence and mortality rates reflect the geographical distribution of the main environmental risk factors [1], [2]. Substantial changes in the epidemiology of HCC are expected to occur because of the prevention of viral hepatitis in most hyperendemic areas, including mass vaccination of newborns which provides a barrier to HCC in subsequent cohorts of adults [3] and control of aflatoxin exposure in China [4]. In parallel, the emergence of HCC related to obesity and diabetes is growing [5], [6]. Moreover, circumstantial evidence indicates that genetic factors are important predictors of cancer risk at the individual level, as suggested by the 3-fold increase in liver cancer among subjects with family history of cancer in first-degree relatives [7]. The ABO blood type, a marker of familial and genetic factors, has previously been associated with the risk of several malignancies, including gastric, epithelial ovarian and pancreatic cancer [8], [9], [10], [11], [12]. A reduced risk of pancreatic cancer has been demonstrated in blood type O, whereas an excess risk of gastric cancer was found in blood type A individuals and an excess risk of ovarian cancer in those with blood type B [8], [9], [10], [11], [12]. However, except for a case-control study performed in China among patients with chronic hepatitis B, where the distribution of blood type A was slightly higher among HCC patients than among controls with chronic hepatitis, there is little data on the association between ABO type and HCC risk [13].
Aim of this study was to evaluate whether an association exists between ABO blood type and HCC.
Section snippets
Methods
This retrospective case–control study enrolled HCC patients who were admitted for any reason in our department between January 2005 and March 2014. All hospital discharges with HCC-related codes (primary or secondary diagnosis) according to the International Classification of Diseases, Ninth Revision, clinical modification (ICD-9CM) who received transfusion of any blood component (erythrocytes, platelets and plasma), according to the procedure codes retrieved from hospital database were
Results
Overall 90,731 subjects were enrolled: 194 with HCC, 215 cirrhotics and 90,322 healthy blood donors. Table 1 reports the characteristics of subjects included in the analysis. We considered all HCC patients with an available blood type admitted to the in-patient department: all were cirrhotic and mean age was 66 years, 75% males and the most frequent aetiology of cirrhosis was HCV (50%), followed by alcohol abuse (17%). Eighty-six patients (45%) were admitted in good general condition (PS 0-1,
Discussion
We demonstrated the existence of a relationship between the ABO blood type and HCC in a Western population. Non-O blood types showed increased risk of HCC development, as previously shown for pancreatic, gastric and epithelial ovarian cancers [9], [10], [11], [12]. The results were of borderline significance when comparing HCC to cirrhotic patients without HCC, due to the relatively limited sample size, but highly significant when compared to a much larger cohort of healthy blood donors.
One
Conflict of interest
None declared.
References (25)
- et al.
Estimates of cancer incidence and mortality in Europe in 2008
European Journal of Cancer
(2010) - et al.
A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
Annals of Oncology
(2013) - et al.
The changing pattern of epidemiology in hepatocellular carcinoma
Digestive and Liver Disease
(2010) - et al.
Family history of cancer and the risk of cancer: a network of case-control studies
Annals of Oncology
(2013) - et al.
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching
Digestive and Liver Disease
(2011) - et al.
ABO blood group and cancer
European Journal of Cancer
(2010) Mortality database
(2008)- et al.
Attributable causes of liver cancer mortality and incidence in China
Asian Pacific Journal of Cancer Prevention
(2013) - et al.
Trends in alcohol consumption in Europe and their impact on major alcohol-related cancers
European Journal of Cancer Prevention
(2013) Blood group antigens: molecules seeking a function?
Glycoconjugate Journal
(1997)
Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study
American Journal of Epidemiology
ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis
American Journal of Epidemiology
Cited by (11)
Current allocation policy is favorable for patients with hepatocellular carcinoma waiting for liver transplantation
2018, Digestive and Liver DiseaseCitation Excerpt :A striking finding of our study was the significantly greater number of patients with A blood group in the HCC than in the non-HCC group (56% vs. 39%). This difference points to A blood group as a risk factor for HCC, in agreement with other studies [23,24]. In this regard, Li et al. examined the incidence of HCC in a cohort of 6275 Chinese patients, and described an adjusted odds ratio of 1.39 [CI 95% 1.05–1.83] for the link between A blood group and HCC in men [23].
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
2021, Frontiers in OncologyAbo Blood Group Differentials On Survival In Hepatocellular Carcinoma Patients Treated With Chemoembolization
2021, Asian Pacific Journal of Cancer Prevention